TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 60,868 | 50,559 | 38,697 |
Financial expenses | 879 | 491 | 486 |
Earnings before taxes | 11,989 | 14,031 | 10,243 |
Total assets | 36,201 | 37,954 | 26,854 |
Current assets | 32,143 | 33,281 | 21,455 |
Current liabilities | 22,113 | 22,352 | 14,129 |
Equity capital | 14,087 | 15,315 | 12,474 |
- share capital | 646 | 682 | 646 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 38.9% | 40.4% | 46.5% |
Turnover per employee | 1,759 | ||
Profit as a percentage of turnover | 19.7% | 27.8% | 26.5% |
Return on assets (ROA) | 35.5% | 38.3% | 40.0% |
Current ratio | 145.4% | 148.9% | 151.9% |
Return on equity (ROE) | 85.1% | 91.6% | 82.1% |
Change turnover | 12,964 | 9,761 | -3,437 |
Change turnover % | 27% | 24% | -8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.